The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sopharma AD (the “Company”) announces that on 22 October 2015 the Company bought 3 080 000 shares from the capital of Medika AD. After this transaction, the share of Sopharma AD in the capital of Medika AD increased to 66.72%.
Sopharma AD notifies that for October 2015 the Company recorded same level of sales revenues compared to the same month of 2014, including 2% increase of domestic sales and 2% decrease of export sales.
For the first ten months of this year, revenues from sales decreased by 16% compared to the same period of 2014, including 2% increase of domestic sales and a 25% decrease of export sales.
Sopharma AD notifies that for November 2015 the Company recorded a decrease of sales revenues of 5% compared to the same month of 2014, including 3% increase of domestic sales and 9% decrease of export sales.
For the first eleven months of this year, revenues from sales decreased by 15% compared to the same period of 2014, including 2% increase of domestic sales and a 23% decrease of export sales.